Class II, Major Histocompatibility Complex, Transactivator (CIITA) (N-Term) Peptide
CIITA
Reactivité: Humain
BP
Sodium azide
-
- Antigène Tous les produits CIITA
- CIITA (Class II, Major Histocompatibility Complex, Transactivator (CIITA))
- Protein Region
- N-Term
- Origine
- Humain
- Application
- Blocking Peptide (BP)
- Attributs du produit
-
16 amino acids near the amino terminus of human CIITA.
Human
-
-
- Indications d'application
- CIITA peptide is used for blocking the activity of CIITA.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Date de péremption
- 12 months
-
- Antigène
- CIITA (Class II, Major Histocompatibility Complex, Transactivator (CIITA))
- Synonymes
- CIITA Peptide, C2ta Peptide, EG669998 Peptide, Gm9475 Peptide, C2TA Peptide, CIITAIV Peptide, MHC2TA Peptide, NLRA Peptide, Mhc2ta Peptide, class II, major histocompatibility complex, transactivator Peptide, class II major histocompatibility complex transactivator Peptide, MHC class II transactivator Peptide, class II transactivator Peptide, CIITA Peptide, LOC710761 Peptide, ciita Peptide, LOC100443575 Peptide, Ciita Peptide, LOC100736732 Peptide
-
Vous êtes ici:
